NBP
Novabridge Biosciences
$1.26
+$0.01 (+0.4%)Oct 28, 2026
Key metrics
The numbers that frame NBP today
- Market cap
- $146.16M
- ROIC
- -265.4%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $1.19
- 52wk High
- $5.19
Growth
Revenue and earnings trend for NBP
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about NBP
Is Novabridge Biosciences a good buy?
No. Novabridge Biosciences has poor quality and poor momentum. Both signals point to a weaker setup.
What is the market capitalization of NBP?
Novabridge Biosciences's market capitalization is $146.16M.
What is the 52-week high for NBP stock?
The 52-week high for Novabridge Biosciences is $5.19. The current close of $1.26 is 75.7% below that high.
What is the 52-week low for NBP stock?
The 52-week low for Novabridge Biosciences is $1.19. The current close of $1.26 is 5.9% above that low.
Does NBP stock pay dividends?
Novabridge Biosciences does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for NBP?
Novabridge Biosciences's Debt / Equity ratio is 0.02.